Integrative proteomics in prostate cancer uncovers robustness against genomic and transcriptomic aberrations during disease progression

10.1038/s41467-018-03573-6

Saved in:

Bibliographic Details
Main Authors:	Latonen, L, Afyounian, E, Jylhä, A, Nättinen, J, Aapola, U, Annala, M, Kivinummi, K.K, Tammela, T.T.L, Beuerman, R.W, Uusitalo, H, Nykter, M, Visakorpi, T
Other Authors:	DUKE-NUS MEDICAL SCHOOL
Format:	Article
Published:	Nature Publishing Group 2020
Subjects:	messenger RNA microRNA proteome transcriptome tumor protein cancer castration citric acid gene expression genetic analysis methylation protein proteomics adult aged Article cancer growth castration resistant prostate cancer citric acid cycle controlled study DNA methylation gene dosage gene expression level genomics human human tissue male mass spectrometry prostate cancer prostate hypertrophy proteogenomics transcriptomics disease exacerbation gene expression regulation genetics genome-wide association study metabolism middle aged pathology prostate Aged Citric Acid Cycle Disease Progression DNA Methylation Gene Dosage Gene Expression Regulation, Neoplastic Genome-Wide Association Study Genomics Humans Male MicroRNAs Middle Aged Neoplasm Proteins Prostate Prostatic Hyperplasia Prostatic Neoplasms, Castration-Resistant RNA, Messenger Transcriptome
Online Access:	https://scholarbank.nus.edu.sg/handle/10635/178420
Tags:	Add Tag No Tags, Be the first to tag this record!
Institution:	National University of Singapore

id	sg-nus-scholar.10635-178420
record_format	dspace
spelling	sg-nus-scholar.10635-1784202023-11-01T09:02:54Z Integrative proteomics in prostate cancer uncovers robustness against genomic and transcriptomic aberrations during disease progression Latonen, L Afyounian, E Jylhä, A Nättinen, J Aapola, U Annala, M Kivinummi, K.K Tammela, T.T.L Beuerman, R.W Uusitalo, H Nykter, M Visakorpi, T DUKE-NUS MEDICAL SCHOOL messenger RNA microRNA proteome messenger RNA microRNA transcriptome tumor protein cancer castration citric acid gene expression genetic analysis methylation protein proteomics adult aged Article cancer growth castration resistant prostate cancer citric acid cycle controlled study DNA methylation gene dosage gene expression level genomics human human tissue male mass spectrometry prostate cancer prostate hypertrophy proteogenomics proteomics transcriptomics disease exacerbation gene expression regulation genetics genome-wide association study genomics metabolism middle aged pathology prostate Aged Citric Acid Cycle Disease Progression DNA Methylation Gene Dosage Gene Expression Regulation, Neoplastic Genome-Wide Association Study Genomics Humans Male MicroRNAs Middle Aged Neoplasm Proteins Prostate Prostatic Hyperplasia Prostatic Neoplasms, Castration-Resistant RNA, Messenger Transcriptome 10.1038/s41467-018-03573-6 Nature Communications 9 1 1176 2020-10-20T09:52:44Z 2020-10-20T09:52:44Z 2018 Article Latonen, L, Afyounian, E, Jylhä, A, Nättinen, J, Aapola, U, Annala, M, Kivinummi, K.K, Tammela, T.T.L, Beuerman, R.W, Uusitalo, H, Nykter, M, Visakorpi, T (2018). Integrative proteomics in prostate cancer uncovers robustness against genomic and transcriptomic aberrations during disease progression. Nature Communications 9 (1) : 1176. ScholarBank@NUS Repository. https://doi.org/10.1038/s41467-018-03573-6 2041-1723 https://scholarbank.nus.edu.sg/handle/10635/178420 Attribution 4.0 International http://creativecommons.org/licenses/by/4.0/ Nature Publishing Group Unpaywall 20201031
institution	National University of Singapore
building	NUS Library
continent	Asia
country	Singapore Singapore
content_provider	NUS Library
collection	ScholarBank@NUS
topic	messenger RNA microRNA proteome messenger RNA microRNA transcriptome tumor protein cancer castration citric acid gene expression genetic analysis methylation protein proteomics adult aged Article cancer growth castration resistant prostate cancer citric acid cycle controlled study DNA methylation gene dosage gene expression level genomics human human tissue male mass spectrometry prostate cancer prostate hypertrophy proteogenomics proteomics transcriptomics disease exacerbation gene expression regulation genetics genome-wide association study genomics metabolism middle aged pathology prostate Aged Citric Acid Cycle Disease Progression DNA Methylation Gene Dosage Gene Expression Regulation, Neoplastic Genome-Wide Association Study Genomics Humans Male MicroRNAs Middle Aged Neoplasm Proteins Prostate Prostatic Hyperplasia Prostatic Neoplasms, Castration-Resistant RNA, Messenger Transcriptome
spellingShingle	messenger RNA microRNA proteome messenger RNA microRNA transcriptome tumor protein cancer castration citric acid gene expression genetic analysis methylation protein proteomics adult aged Article cancer growth castration resistant prostate cancer citric acid cycle controlled study DNA methylation gene dosage gene expression level genomics human human tissue male mass spectrometry prostate cancer prostate hypertrophy proteogenomics proteomics transcriptomics disease exacerbation gene expression regulation genetics genome-wide association study genomics metabolism middle aged pathology prostate Aged Citric Acid Cycle Disease Progression DNA Methylation Gene Dosage Gene Expression Regulation, Neoplastic Genome-Wide Association Study Genomics Humans Male MicroRNAs Middle Aged Neoplasm Proteins Prostate Prostatic Hyperplasia Prostatic Neoplasms, Castration-Resistant RNA, Messenger Transcriptome Latonen, L Afyounian, E Jylhä, A Nättinen, J Aapola, U Annala, M Kivinummi, K.K Tammela, T.T.L Beuerman, R.W Uusitalo, H Nykter, M Visakorpi, T Integrative proteomics in prostate cancer uncovers robustness against genomic and transcriptomic aberrations during disease progression
description	10.1038/s41467-018-03573-6
author2	DUKE-NUS MEDICAL SCHOOL
author_facet	DUKE-NUS MEDICAL SCHOOL Latonen, L Afyounian, E Jylhä, A Nättinen, J Aapola, U Annala, M Kivinummi, K.K Tammela, T.T.L Beuerman, R.W Uusitalo, H Nykter, M Visakorpi, T
format	Article
author	Latonen, L Afyounian, E Jylhä, A Nättinen, J Aapola, U Annala, M Kivinummi, K.K Tammela, T.T.L Beuerman, R.W Uusitalo, H Nykter, M Visakorpi, T
author_sort	Latonen, L
title	Integrative proteomics in prostate cancer uncovers robustness against genomic and transcriptomic aberrations during disease progression
title_short	Integrative proteomics in prostate cancer uncovers robustness against genomic and transcriptomic aberrations during disease progression
title_full	Integrative proteomics in prostate cancer uncovers robustness against genomic and transcriptomic aberrations during disease progression
title_fullStr	Integrative proteomics in prostate cancer uncovers robustness against genomic and transcriptomic aberrations during disease progression
title_full_unstemmed	Integrative proteomics in prostate cancer uncovers robustness against genomic and transcriptomic aberrations during disease progression
title_sort	integrative proteomics in prostate cancer uncovers robustness against genomic and transcriptomic aberrations during disease progression
publisher	Nature Publishing Group
publishDate	2020
url	https://scholarbank.nus.edu.sg/handle/10635/178420
_version_	1781792295034552320

Integrative proteomics in prostate cancer uncovers robustness against genomic and transcriptomic aberrations during disease progression

Similar Items